Clinical Trials Logo

Rupture clinical trials

View clinical trials related to Rupture.

Filter by:

NCT ID: NCT03607929 Recruiting - Pregnancy Clinical Trials

HIDRATA Study: Efficacy of a Hydration Protocol in Nulliparous Women During Labor

HYDRATA
Start date: June 1, 2018
Phase: N/A
Study type: Interventional

Aim. To evaluate the efficacy of optimizing hydration during labor in nulliparous women with respect to reducing the duration of dilation and the second stage of labor, lowering the incidence of Cesarean sections and fever, and also with respect to changes in sodium and osmolarity in blood and urine, and 24 hour diuresis. Background. In the international scientific community there is a lack of consensus regarding the most suitable hydration strategies to be used in the attention of nulliparous women during low risk birth. Insufficient hydration during labor is associated with increased maternal and neonatal morbidity. Design. A randomized, controlled clinical trial with allocation concealment and masking during the evaluation of the results. Methods. A study of nulliparous women whose births and newborn are attended in the Obstetric Service of a University Hospital. The women will be randomized to two groups: the "optimal hydration" group, that will be guaranteed 300 ml/h (intravenous crystalloids and water) with a minimum diuresis of 400 ml/24h; and the "variability in hydration" group, comprised of the administration of intravenous and clear liquid volumes, without any established perfusion rate, based on criteria established by the healthcare professional attending the birth, and without established minimum diuresis. Mother outcomes: duration of labor, Cesarean section, fever, dehydration. Newborn outcomes: distress, hypoglycemia, hyponatremia, jaundice, weight loss in 48h, breastfeeding difficulties. Analysis will be per-protocol. Statistical significance will be set at p<0.05 Discussion. The findings obtained in this study will provide new evidence for considering the benefits of providing women with suitable optimized hydration during labor. Diminishing the clinical practice variability related to hydration strategies applied to nulliparous women attended during labor through the use of a decision-making algorithm to administer optimal hydration, would imply improved health and safety for mothers and their newborn together with reduced maternal and neonatal morbidity. Funding granted in 2015 by the Spanish Health Research Fund (PI 15/00897, Ministry of Health). Keywords: hydration; dehydration; adverse events; labor; Cesarean section, fever.

NCT ID: NCT03561311 Recruiting - Aneurysm, Ruptured Clinical Trials

The Neuroprotective Effect of Remote Ischemic Conditioning in Ruptured Aneurysm Coiling Therapy

NEAT-2
Start date: October 6, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

The overall incidence of DWI positive for thromboembolic events following endovascular treatment of intracranial aneurysms is proximately 50%. Whether remote ischemic conditioning was safe and effective to reduce ischemic brain lesions on DWI after endovascular treatment of intracranial aneurysms is still unclear. The investigators' hypothesis is that remote ischemic conditioning is a safe and effective strategy to reduce new ischemic lesions in intracranial aneurysms patients undergoing endovascular treatment.

NCT ID: NCT03440697 Recruiting - Clinical trials for Aortic Valve Disease

Pathogenetic Basis of Aortopathy and Aortic Valve Disease

TAA
Start date: December 10, 2015
Phase:
Study type: Observational

The main purpose of this study is to define the complex genetic and pathogenic basis of thoracic aortic aneurysm (TAA) and other forms of aortopathy and/or aortic valve disease by identifying novel disease-causing genes and by identifying important genetic modifiers for aortic and aortic valve disease severity.

NCT ID: NCT03435263 Recruiting - Clinical trials for Management of Women With PROM at Term

Hospital Admission Versus Home Management in Women With Premature Rupture of Membranes :RCT

Start date: February 1, 2018
Phase: N/A
Study type: Observational

According to high tendency for admission of cases of premature rupture of membranes (PROM) for fear of maternal & fetal complications, we compare here between cases managed at hospital with other managed at home for if there any difference between in maternal and neonatal outcome.

NCT ID: NCT03399266 Recruiting - Clinical trials for Prelabor Rupture of Membranes

Balloon Induction of Labor in PROM for TOLAC

BILROM-TOLAC
Start date: March 1, 2018
Phase: N/A
Study type: Interventional

A prospective randomized controlled trial to evaluate the safety and efficacy of labor induction with a double balloon catheter (Atad Ripener Device) in women desiring TOLAC (trial of labor after cesarean) with PROM (pre labor rupture of membranes).

NCT ID: NCT03359382 Recruiting - ACL Injury Clinical Trials

The Rehabilitation Effect of Exercise Training in Cruciate Ligament Reconstruction Patients.

Start date: November 1, 2017
Phase: N/A
Study type: Interventional

After anterior cruciate ligament (ACL) injury, the involved quadriceps may demonstrate weakness due to decrease in quadriceps activation. However, elapsed time from the injury may affect muscle strength by restoration of the quadriceps activation. The injury is characterized by joint instability that leads to decreased activity, unsatisfactory knee function, and poor knee-related quality of life in the short term, and it is associated with an increased risk of osteoarthritis on the knee. This study was designed to compare muscle strength, questionnaire and knee function in patients with different exercise training.

NCT ID: NCT03312088 Recruiting - Infection Clinical Trials

Maxx Orthopedics' PCK Revision TKA Study of Component Survivorship

Start date: January 1, 2019
Phase:
Study type: Observational

The objectives of this clinical investigation are to evaluate the safety and performance of the Freedom Total Knee® PCK System.

NCT ID: NCT03310333 Recruiting - Clinical trials for PROM (Premature Rupture Of Foetal Membrane)

Cook Balloon Versus Propess After 12 Hours of Rupture of Membranes

RUBAPRO
Start date: February 14, 2018
Phase: Phase 4
Study type: Interventional

The objective is to demonstrate the superiority of the strategy of labor induction by Cook® cervical ripening balloon between recommended strategy by dinoprostone (propess®) on the reduction of the time between cervical ripening and delivery in case of unfavorable cervix after 12 hours of PROM in term pregnant women.

NCT ID: NCT03306719 Recruiting - Clinical trials for Preterm Premature Rupture of Membrane

mtDNA as Novel Biomarker for Intra-amniotic Infection

mtDNA
Start date: April 5, 2017
Phase: N/A
Study type: Observational

Finding a predictive biomarker for IAI could improve the clinical outcome for the mother and the neonate. The aim of this study is to quantify the copy number of circulating cell-free mitochondrial DNA in maternal serum and the placenta compared to controls.the investigators hypothesise that circulating cell-free mitochondrial DNA levels could help predict the likelihood of early inflammation in IAI. In addition, mitochondrial DNA could be a promotor triggering the pathogenesis of systemic inflammation.

NCT ID: NCT03259204 Recruiting - Clinical trials for Venous Thromboembolism

Swedish Multicenter Trial of Outpatient Prevention of Leg Clots

StopLegClots
Start date: September 1, 2018
Phase: N/A
Study type: Interventional

Lower limb immobilization is associated with high risk of complications, i.e. venous thromboembolism (VTE) and failed healing. Pharmacoprophylaxis of VTE is in leg-immobilized patients, however, low- or non-effective and associated with adverse events. Thus, there is a need for novel treatments. This study aims to demonstrate in leg immobilized patients who have suffered an ankle fracture (1000 patients) or an Achilles tendon rupture (400 patients) that adjuvant intermittent pneumatic compression (IPC) therapy, which targets impaired vascular flow, compared to treatment-as-usual with plaster cast, reduces VTE incidence and improves healing.